Superoxide dismutase (SOD) is a redox metalloenzyme that serves as a critical defense against oxidative damage caused by reactive oxygen species, with applications across food, cosmetic, and pharmaceutical industries. However, the limited catalytic activity and poor thermostability restrict its effectiveness in industrial processes. Herein, we report a SOD from Deinococcus wulumuqiensis R12 (SOD(R12)) that demonstrates remarkable catalytic activity of 1356.7 U/mg protein, and retains 48.1 % residual activity at 100 °C for 60 min. We further employed computational-guided rational design and combinatorial experiments, resulting in the engineered SOD(R12) variants with improved activity and thermostability. Among these, the D120L variant retains 87.2 % residual activity at 100 °C for 60 min, while the G109H variant shows the highest activity of 3322.5 U/mg protein. Moreover, the E47S variant achieves a specific activity of 1726.9 U/mg protein, and retains 89.4 % residual activity. Molecular dynamics simulations reveal that the D120L variant exhibits a highly rigid structure, while the G109H variant benefits from enhanced electron transfer mediated by in salt bridge modifications. Then, the E47S variant shows a balance between structural flexibility and rigidity. This study demonstrates a robust strategy for boosting enzyme activity and thermostability, offering valuable insights for optimizing SOD performance and guiding future enzyme engineering efforts.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijbiomac.2025.141871 | DOI Listing |
Small
March 2025
State Key Laboratory of Advanced Medical Materials and Devices, Medical College, Tianjin University, Tianjin, 300072, China.
Irreversible electroporation (IRE) is a minimally invasive, non-thermal tumor ablation technique that induces nanoscale membrane perforation, leading to immunogenic cell death (ICD). However, IRE alone is limited by uneven electric field attenuation, incomplete tumor ablation, and the immunosuppressive nature of the tumor microenvironment. To address these challenges, a multifunctional nanomaterial, vermiculite nanosheets/calcium peroxide nanosheets (VMT/CaO NSs), is developed to enhance the efficacy of IRE.
View Article and Find Full Text PDFCancer Biol Med
March 2025
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Objective: Our previous studies have indicated potentially higher proliferative activity of tumor cells in Chinese patients with mantle-cell lymphoma (MCL) than those in Western. Given the success and tolerability of R-DA-EDOCH immunochemotherapy in treating aggressive B-cell lymphomas, we designed a prospective, phase 3 trial to explore the efficacy and safety of alternating R-DA-EDOCH/R-DHAP induction therapy for young patients with newly diagnosed MCL. The primary endpoint was the complete remission rate (CRR) at the end of induction (EOI).
View Article and Find Full Text PDFCureus
February 2025
Gastroenterology, Icahn School of Medicine at Mount Sinai, Queens, USA.
Hepatolithiasis is a condition characterized by the presence of bile stones in the intrahepatic bile ducts. It represents a significant therapeutic challenge owing to its association with recurrent cholangitis, biliary obstruction, and potentially life-threatening complications such as hepatic abscesses and cholangiocarcinoma. Traditional treatments include hepatectomy and percutaneous transhepatic cholangioscopic lithotomy (PTCL), both of which are effective but highly invasive, whereas endoscopic approaches often leave residual stones.
View Article and Find Full Text PDFJ Fish Biol
March 2025
Northwest Atlantic Fisheries Centre, Fisheries and Oceans Canada, St. John's, Newfoundland Island, Canada.
Larval fish are active planktonic predators, with many species feeding initially on copepod nauplii and gradually shifting their selection to copepodites. This study evaluated whether it is possible to develop a general widely applicable empirical model to describe the transition from feeding on copepod nauplii to copepodites in relation to body length, maxilla length and eye diameter. The study also evaluated whether the switch to copepodites is linked to what prey are in the stomach or which copepodite species are replacing nauplii in the diet was also considered.
View Article and Find Full Text PDFBMC Cancer
March 2025
Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Background: Atezolizumab plus bevacizumab is recommended as a first-line treatment for unresectable hepatocellular carcinoma (uHCC). A subgroup analysis of the IMbrave150 trial showed shorter overall survival (OS) in uHCC patients with stable disease (SD) than patients with complete response (CR) or partial response (PR) after atezolizumab plus bevacizumab. Improving OS in patients with SD is an unmet medical need.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!